https://www.selleckchem.com/pr....oducts/pf-00835231.h
Of the 4 patients (5.7%) with metastatic LNs, 3 were pathologically classified as beyond the expanded indication for ESD and 1 had a single LN metastasis in the regional lymph node. RLND is a safe additional option for the treatment of EGC in patients meeting expanded indications after ESD. RLND is a safe additional option for the treatment of EGC in patients meeting expanded indications after ESD. Various studies have indicated that reduced-port robotic gastrectomies are safe and feasible for treating patients with early gastric ca
Beğen
Yorum Yap
Paylaş
